1887

Abstract

A case of haemolytic uraemic syndrome following dysentery due to ciprofloxacin-resistant serotype 1 is reported for the first time. The increasing resistance of serotype 1 to many commonly available antimicrobial agents has implications for the management of dysentery. The choice of antimicrobial treatment for serotype 1 infections should take into account widespread drug resistance and the risk of haemolytic uraemic syndrome.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45993-0
2005-10-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/10/JM541016.html?itemId=/content/journal/jmm/10.1099/jmm.0.45993-0&mimeType=html&fmt=ahah

References

  1. Bauer, A. W., Kirby, W. M., Sherries, J. C. & Turck, M. ( 1995;). Antibiotic susceptibility testing by a single method. Am J Clin Pathol 45, 493–496.
    [Google Scholar]
  2. Bennish, M. L., Harris, J. R., Wojtyniak, B. J. & Struelens, M. ( 1990;). Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis 161, 500–506.[CrossRef]
    [Google Scholar]
  3. Bhimma, R., Rollins, N. C., Coovadia, H. M. & Adhikari, M. ( 1997;). Post-dysenteric hemolytic uraemic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 11, 560–564.[CrossRef]
    [Google Scholar]
  4. Bhuyan, V. N., Srivastava, R. N. & Choudhry, V. P. ( 1985;). Pathology of acute renal failure and haemolytic uraemic syndrome in acute dysentery in children. Indian J Med Res 81, 402. 402.
    [Google Scholar]
  5. Butler, T., Islam, M. R., Azad, M. A. & Jones, P. K. ( 1987;). Risk factors for development of haemolytic uraemic syndrome during shigellosis. J Pediatr 110, 894–897.[CrossRef]
    [Google Scholar]
  6. Karmali, M. A., Steele, B. T., Petric, M. & Lim, C. ( 1983;). Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet i, 619–620.
    [Google Scholar]
  7. Koster, F. T., Levin, J., Walker, L., Tung, K. S., Gilman, R. H., Rahaman, M. M., Majid, M. A., Islam, S. & Williams, R. C., Jr ( 1978;). Hemolytic-uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N Engl J Med 298, 927–933.[CrossRef]
    [Google Scholar]
  8. Koster, F. T., Boonpucknavig, V., Sujaho, S., Gilman, R. H. & Rahaman, M. M. ( 1984;). Renal histopathology in haemolytic uremic syndrome following shigellosis. Clin Nephrol 21, 126. 126.
    [Google Scholar]
  9. Legros, D., Paquet, C., Dorlencourt, F. & Saoult, E. ( 1999;). Risk factors for death in hospitalised dysentery patients in Rwanda. Trop Med Int Health 4, 428–432.[CrossRef]
    [Google Scholar]
  10. Lopez, E. L., Diaz, M., Grinstein, S. & 10 other authors ( 1989;). Haemolytic uraemic syndrome and diarrhoea in Argentine children: the role of Shiga-like toxins. J Infect Dis 160, 469–475.[CrossRef]
    [Google Scholar]
  11. Nathoo, K. J., Sanders, J. A., Siziya, S. & Mucheche, C. ( 1995;). Haemolytic uraemic syndrome following Shigella dysenteriae type 1 outbreak in Zimbabwe: a clinical experience. Cent Afr J Med 41, 267–274.
    [Google Scholar]
  12. Nathoo, K. J., Porteous, J. E., Siziya, S., Wellington, M. & Mason, E. ( 1998;). Predictors of mortality in children hospitalised with dysentery in Harare, Zimbabwe. Cent Afr J Med 44, 272–276.
    [Google Scholar]
  13. NCCLS ( 2000;). Performance Standards for Antimicrobial Susceptibility Testing; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard, 5th edn. Publication M7-A5, vol. 20, no. 2. Wayne, PA: National Committee for Clinical Laboratory Standards.
  14. Oneko, M., Nyathi, M. N. & Doehring, E. ( 2001;). Post-dysenteric hemolytic uremic syndrome in Bulawayo, Zimbabwe. Pediatr Nephrol 16, 1142–1145.[CrossRef]
    [Google Scholar]
  15. Raghupathy, P., Date, A., Shastry, J. C., Sundarsanam, A. & Jadhav, M. ( 1978;). Haemolytic-uraemic syndrome complicating shigella dysentery in south Indian Children. BMJ 1, 1518–1521.[CrossRef]
    [Google Scholar]
  16. Remuzzi, G. & Ruggenenti, P. ( 1995;). The haemolytic uraemic syndrome. Kidney Int 48, 2–19.[CrossRef]
    [Google Scholar]
  17. Rollins, N. C., Wittenberg, D. F., Coovadia, H. M., Pillay, D. G., Karas, A. J. & Sturm, A. W. ( 1995;). Epidemic Shigella dysenteriae type 1 in Natal. J Trop Pediatr 41, 281–284.[CrossRef]
    [Google Scholar]
  18. Safdar, N., Said, A., Gangnon, R. E. & Maki, D. G. ( 2002;). Risk of hemolytic uraemic syndrome after antibiotic treatment of Escherichia coli O157 : H7 enteritis. JAMA 288, 996–1001.[CrossRef]
    [Google Scholar]
  19. Scotland, S. M., Rowe, B., Smith, H. R., Willshaw, G. A. & Gross, R. J. ( 1988;). Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol 25, 237–243.[CrossRef]
    [Google Scholar]
  20. Siegler, R. L. ( 1995;). The hemolytic uraemic syndrome. Pediatr Clin North Am 42, 1505–1529.
    [Google Scholar]
  21. Tarr, P. I., Gordon, C. A. & Chandler, W. L. ( 2005;). Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073–1086.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45993-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error